Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+223K
-
Total reported value, excl. options
-
$93.3M
-
Value change
-
+$965K
-
Put/Call ratio
-
0.21
-
Number of buys
-
49
-
Number of sells
-
-23
-
Price
-
$4.93
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2024
96 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2024.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 37.4M outstanding shares and own 50.58% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (4.92M shares), Legion Partners Asset Management, LLC (2.97M shares), Greenhaven Road Investment Management, L.P. (2.23M shares), BlackRock, Inc. (1.51M shares), 325 CAPITAL LLC (1.37M shares), VANGUARD GROUP INC (1.32M shares), MORGAN STANLEY (777K shares), GEODE CAPITAL MANAGEMENT, LLC (598K shares), STATE STREET CORP (334K shares), and DEUTSCHE BANK AG\ (316K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.